Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
Cutaneous Angiosarcoma
Interventions
DRUG

Paclitaxel

-Commercial supply

RADIATION

Radiation therapy

-Patients may be treated with electrons, 3D conformal photon radiotherapy, intensity modulated photon radiotherapy (IMRT), proton radiation therapy, or a combination of these.

PROCEDURE

Research blood draw

-Within 1 week (prior to cycle 1 of paclitaxel preferred but not required), pre-radiation therapy (any time weeks 5-7 as long as radiation therapy has not started), post-radiation therapy (day of last fraction), 14 days post-radiation therapy, and within 2 weeks post-surgery

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER